The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
TRAZODONE IN BENZODIAZEPINE DEPENDENCE
Abstract
*Psychiatric Unit, C.H.U. du Sart Tilman, B-4000 Liège and **Department of Psychiatry, U.Z., B-9940 Antwerpen, Belgium
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Regarding BZD discontinuation, only one study 91 has investigated the potential role of trazodone in facilitating the process.”
From Z-drug abuse and dependence: Clinical guideline of the Brazilian Academy of Neurology for diagnosis and management (2025) · cites this paper as [91]
In the citing paper
“The use of trazodone was associated with a reduction in withdrawal symptoms and a decreased need for prolonged BZD use over a 12-month follow-up.”
From Z-drug abuse and dependence: Clinical guideline of the Brazilian Academy of Neurology for diagnosis and management (2025) · cites this paper as [91]
In the citing paper
“Moreover, the patients experienced improvements in anxiety and depressive symptoms.”
From Z-drug abuse and dependence: Clinical guideline of the Brazilian Academy of Neurology for diagnosis and management (2025) · cites this paper as [91]
Citations
Cites
Trazodone in benzodiazepine dependence.
Ansseau, M., & Roeck, J. D. (1993) · PubMed · Cited by 30
Self-citation
Cited by
Sorted by citations
Stelzer, F. G., Bacelar, A., Éckeli, A. L., Negrão, A. B., Almeida, C. M. O., Franco, C. M. R., Pires, G. N., Gitaí, L. L. G., Sobreira-Neto, M. A., Assis, M., et al. (2025) · Arquivos de Neuro-Psiquiatria · doi:10.1055/s-0045-1812323 · Cited by 1
“The authors 91 suggested that antidepressants with pharmacological properties similar to trazodone may play a bene fi cial role in facilitating BZD discontinuation, particularly in individuals presenting with comorbid anxiety or depression.”
Metadata
- Authors
- Ansseau, M., & De Roeck, J.
- Affiliations
- Centre Hospitalier Universitaire de Liège (BE)
- Corresponding author
- Ansseau, M.
- Venue
- Clinical Neuropharmacology
- Published
- 1992
- Volume
- 15
- Pages
- 634B
- ISSN
- 0362-5664 (ISSN-L)
- OpenAlex
- W2314476045
- Cited by
- 3
- References
- 1
- Citations by year
- 2025: 1 · 2022: 1
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Neuropharmacology (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- trazodone, benzodiazepine dependence, benzodiazepine withdrawal, antidepressants, drug addiction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
